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Abstract
RNA interference (RNAi) has been shown to spread from cell to cell in plants and in
Caenorhabditis elegans, but it does not spread in other organisms, such as Drosophila. A recent
report demonstrates that a membrane channel, encoded by the gene sid-1, is responsible for the
spreading of RNAi between cells.
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RNA interference (RNAi) is the phenomenon by which
double-stranded RNA (dsRNA) sequences trigger the
sequence-specific degradation of homologous endogenous
mRNAs. RNAi was discovered serendipitously in 1998, when
Andrew Fire and colleagues [1] were attempting to block
gene expression by injection of antisense RNA into adult
Caenorhabditis elegans. They discovered that the double-
stranded RNA side-products of their RNA synthesis reac-
tions were more effective inhibitors than single-stranded
antisense RNA. Concentrated solutions of dsRNA have since
become a potent experimental tool for inhibiting gene
expression in C. elegans and other model organisms, includ-
ing Drosophila. 
RNAi in C. elegans has two striking characteristics. First, it
is extremely specific and only targets mRNA sequences that
are identical, not those that are closely related or highly
homologous. Second, it is systemic: injection of dsRNA into
the gut of a hermaphrodite individual allows gene suppres-
sion in most tissues of the animal, as well as effective sup-
pression in most tissues of the animal’s progeny. This
‘spreading’ characteristic underlies some of the most sur-
prising observations in the short history of RNAi: namely
that simply soaking worms in a solution of dsRNA [2], or
feeding them transformed bacteria expressing dsRNA
encoding a gene of choice [3], selectively suppresses the
function of that gene in all of the individual’s progeny. The
latter ‘feeding’ induction technique has enabled successful
large-scale genome-wide screens, in which banks of trans-
genic strains of Escherichia coli, each engineered to produce
dsRNA for a single gene of the C. elegans genome, have been
used to screen C. elegans genes for roles in embryonic devel-
opment, genome stability, fat metabolism, longevity, and
other biological processes [4-8].
As befits a pathway with such basic biological significance
and such tremendous experimental potential, a great deal of
recent work has gone into understanding the molecular
mechanisms of RNAi. In the last five years great strides have
been made in understanding the mechanisms by which
dsRNA targets mRNA transcripts. The current picture
(reviewed in [9,10]) is that dsRNA is cleaved into fragments
of 21-23 nucleotides by the Dicer family of RNAse III
enzymes. These short dsRNA fragments are then incorpo-
rated into another enzyme complex, called the RNA-induced
silencing complex (RISC). The antisense strand of the
dsRNA fragment targets the homologous mRNA for cleav-
age. In contrast, however, surprisingly little is known about
the mechanisms that allow the spreading of RNAi from cell
to cell; for instance, it is not known what kind of molecule
conveys the systemic RNAi signal, nor why some tissue types
in C. elegans, such as the nervous system, are more resistant
to systemic RNAi than others. Two recent publications from
the Hunter lab [11,12] have now made significant progress inthis direction. The first contribution, from 2002 [11],
describes a successful screening strategy for identifying
genes involved in this non-autonomous spreading of RNAi.
The second, appearing in September 2003 [12], character-
izes one of these genes and shows that it encodes a putative
channel protein that functions in the uptake of dsRNA
across cell membranes.
Hunter and colleagues took a clever approach to identify
genes supporting the non-autonomous effects of RNAi. They
constructed a strain of C. elegans that visibly demonstrates
both cell-autonomous and non-autonomous RNAi and
screened for mutants in which non-autonomous RNAi fails
but cell-autonomous RNAi persists. The strain, described by
Winston et al. [11], is one in which expression of green fluo-
rescent protein (GFP) is driven in the muscles of both the
pharynx and the body wall. Expression of a dsRNA that
targets and silences the GFP gene is then driven by a trans-
gene construct that expresses a hairpin (double-stranded)
RNA only in pharyngeal muscles. This dsRNA triggers sup-
pression of GFP in pharyngeal muscles, demonstrating that
cell-autonomous RNAi is still functional, but it also triggers
partial suppression of GFP expression in body-wall muscles,
demonstrating systemic spreading of RNAi. The authors [11]
completely silenced all GFP expression in this strain by addi-
tionally feeding these worms on transformed E. coli express-
ing  GFP dsRNA, further demonstrating non-autonomous
RNAi. They then mutagenized the strain to identify progeny
in which GFP expression was suppressed in pharyngeal
muscles but retained body-wall muscles. In such strains, the
loss of GFP in pharyngeal muscles should confirm that cell-
autonomous RNAi mechanisms remain intact, while the per-
sistent expression of GFP in body-wall muscles suggests that
the RNAi no longer spreads systemically to neighboring
cells. Three complementation groups of ‘systemic RNAi-defi-
cient’ animals were identified using this approach, and the
mutations were mapped to genetic loci called sid-1, sid-2,
and sid-3.
The sid-1 gene encodes a 776-amino-acid protein with multi-
ple stretches of hydrophobic amino acids, and Sid1-GFP
fusion proteins concentrate at cell membranes [11]. Together,
these data suggest that the Sid-1 gene product functions as a
membrane channel for an RNAi-inducing signal. Using a -
galactosidase protein-fusion assay, Feinberg and Hunter [12]
have now shown that the amino terminus of Sid-1 is extracel-
lular and that multiple hydrophobic sequences in Sid-1
indeed span the plasma membrane of expressing cells. A
membrane channel for RNAi could conceivably function
either in the export and/or in the import of an RNAi signal:
demonstration that sid-1 is required cell-autonomously
would indicate a function for the protein in the import of an
RNAi signal, whereas demonstration that the protein func-
tions non-cell-autonomously would be consistent with a role
in export of RNAi. Hunter and colleagues addressed this
issue in the original report describing the identification of
sid-1 [11]. Using an extrachromosomal transgene array
driving mosaic expression of a sid-1-rescue transgene and a
reporter construct encoding the red fluorescent protein
DsRed in sid-1 mutants, they tested the ability of GFP expres-
sion in body-wall muscles to be repressed by exogenous GFP
dsRNA. In these sid-1 mosaic animals, cells that were
observed to have silenced GFP expression (indicating effec-
tive systemic RNAi) were found to be marked by DsRed, indi-
cating that they also expressed functional Sid-1 from the
extrachromosomal array, whereas neighboring cells in which
GFP was not silenced (those resistant to systemic RNAi) all
lacked Sid-1 expression [11]. Thus, Hunter and colleagues [11]
inferred that sid-1 is required for import of an RNAi signal.
(The authors do not, however, exclude the possibility that sid-
1 may also be required for export of an RNAi signal.)
In their more recent work, Feinberg and Hunter [12] have
shown that sid-1 is not only required for systemic RNAi but
is also sufficient when ectopically expressed to promote
uptake of dsRNA in cultured cells of Drosophila. Flies lack
an endogenous sid-1 ortholog, but despite this, Drosophila
cells (such as the S2 cell line) are known to be susceptible to
RNAi induced by dsRNA in their culture medium [13,14].
Feinberg and Hunter [12] have shown, however, that S2 cells
expressing Sid-1 showed equivalently effective RNAi of a
luciferase transgene at dsRNA concentrations 10,000 times
less than those required by cells lacking Sid-1 function. This
effect appeared to be dependent on dsRNA length, as Sid-1
facilitated RNAi much more when cells were soaked in a
solution of 500 base-pair (bp) dsRNAs than when they were
soaked with 50 bp dsRNAs or 21 bp small interfering RNAs
(siRNAs). Using a similar cell-culture assay, the authors
[12] went on to show that Sid-1-mediated uptake of dsRNA
probably takes place by a passive-diffusion mechanism: if
transport were active it would be reduced in cold or energy-
depleted conditions, but in fact the uptake of radiolabeled
dsRNA by Sid-1-expressing S2 cells was affected by cold or
ATP depletion less than the uptake of dsRNA by cells lacking
functional Sid-1. Thus, the authors arrived at a model by
which Sid-1 functions as a transmembrane channel protein,
allowing passive diffusion of dsRNA into cells.
If RNAi functions as a primitive adaptive immune response,
as has been postulated (discussed in [15]), then Sid-1 may
clearly have a function in supplying cells with the dsRNA
trigger for such a response. Consistent with such a role,
endogenous Sid-1 in C. elegans appears to be expressed
maximally in the cells that are exposed to the environment,
such as those of the gut [11]. Beyond natural roles for the
protein, however, as Feinberg and Hunter [12] concluded,
Sid-1-mediated dsRNA uptake may have numerous thera-
peutic and experimental applications. Experimentally, high-
throughput dsRNA ‘soaking’ screens of cell lines [16] may be
made more efficient by transgenic expression of Sid-1. Cell
lines that are otherwise refractory to such a soaking
approach may be made responsive by expression of Sid-1.
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Genome Biology 2004, 5:208Although RNAi induced by dsRNA transgenes in Drosophila
is cell-autonomous and non-systemic [17], there is some evi-
dence for the susceptibility of fly larvae to RNAi by soaking
or ingesting dsRNA solutions [18] and for the susceptibility
of adults to intra-abdominal dsRNA injection [19]. Soaking
or injection screens in Drosophila or other organisms that
lack effective systemic RNAi, such as vertebrates, may be
dramatically improved by creation of strains ubiquitously
expressing exogenous Sid-1. Feinberg and Hunter [12] pos-
tulate that manipulating levels of Sid-1 in vertebrates may
facilitate the future therapeutic use of RNAi to modulate
gene expression in vivo. Such applications may depend on
the size-dependence of dsRNA transport mediated by Sid-1,
however, as longer dsRNA sequences provoke non-specific
responses in vertebrate cells. Potential RNAi-based thera-
pies have focused on the application of short siRNA
sequences [20,21]. Nonetheless, the description of sid-1
makes an extremely important contribution to our under-
standing of the systemic nature of RNAi in C. elegans, an
under-researched aspect of this fundamentally important
biological phenomenon. Characterization of Sid-2 and Sid-3
is eagerly awaited. 
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